Prism Medico

  • Market Cap: Micro Cap
  • Industry: Non Banking Financial Company (NBFC)
  • ISIN: INE730E01016
  • NSEID:
  • BSEID: 512217
INR
27.40
1.02 (3.87%)
BSENSE

Apr 02

BSE+NSE Vol: 11.63 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Prism Medico
Minolta Finance
Kinetic Trust
Visagar Finan.
Decillion Financ
Rita Finance and
Maruti Global In
GSL Securities
Jolly Plastic
Shree Securities
Typhoon Fin Ser

Why is Prism Medico & Pharmacy Ltd ?

1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0
  • The company has been able to generate a Return on Equity (avg) of 0.59% signifying low profitability per unit of shareholders funds
2
Flat results in Dec 25
  • NO KEY NEGATIVE TRIGGERS
3
With ROE of 4, it has a Expensive valuation with a 1.1 Price to Book Value
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 112.24%, its profits have risen by 77% ; the PEG ratio of the company is 0.1
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Non Banking Financial Company (NBFC))

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Prism Medico for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Prism Medico
112.24%
1.92
58.40%
Sensex
-4.3%
-0.32
13.38%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-33.56%
EBIT Growth (5y)
1.55%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
1.90
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.65
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-2.23%
ROE (avg)
0.59%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
27
Industry P/E
55
Price to Book Value
1.10
EV to EBIT
16.54
EV to EBITDA
16.54
EV to Capital Employed
1.10
EV to Sales
7.42
PEG Ratio
0.06
Dividend Yield
NA
ROCE (Latest)
-0.53%
ROE (Latest)
4.04%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
PAT(9M)

Higher at Rs 0.57 Cr

-1What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...

Here's what is working for Prism Medico

Profit After Tax (PAT) - Nine Monthly
Higher at Rs 0.57 Cr
than preceding 12 month period ended Dec 2025 of Rs -0.05 cr
MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months

PAT (Rs Cr)